Skip to Main content Skip to Navigation
Journal articles

Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma a propensity score analysis from a French multicentric cohort

Abstract : Background - The benefit of adjuvant chemotherapy (AC) after pancreaticoduodenectomy (PD) for distal cholangiocarcinoma (DCC) remains controversial. The study aimed to evaluate the impact of AC after PD for DCC in a large multicentric cohort. Methods - Patients from five French centers who underwent from PD for DCC between 2000 and 2015 and received AC (AC+ group) or surgery only (AC- group) were included in the analysis. Variables associated with AC administration were analyzed by univariate analysis. The Cox regression identified covariates associated with overall survival (OS) and disease-free survival (DFS). The AC+ cohort was matched to the AC- cohort (1:1) by a propensity score (PS) based on the likelihood of AC administration and independent factors associated with decreased OS and DFS. Results - Of the 178 patients included, 56 (31.5%) received AC. In the whole cohort, no difference on OS and DFS between the AC+ and AC- groups was identified (P = 0.15 and P = 0.07, respectively). After PS matching, the AC+ group (n = 49) was comparable to the AC- group (n = 49) on factors associated with AC administration and on factors associated with a decreased survival in the large cohort. After matching, the medians of OS and DFS in the AC+ group and in the AC- group were comparable (26.27 vs 43.33 months, P = 0.34, and 15.47 vs. 14.70 months, P = 0.79, respectively). Conclusion - Our study did not demonstrate a survival benefit of adjuvant chemotherapy (mostly base on gemcitabine regimen) for DCC after PD even after propensity score matching. New trial specially designed for DCC is urgently needed to improve survival after surgical resection.
Document type :
Journal articles
Complete list of metadatas

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01862576
Contributor : Laurent Jonchère <>
Submitted on : Monday, August 27, 2018 - 2:24:35 PM
Last modification on : Tuesday, May 26, 2020 - 2:09:58 AM

Identifiers

Citation

Damien Bergeat, Olivier Turrini, Laetitia Courtin-Tanguy, Stéphanie Truant, Benjamin Darnis, et al.. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma a propensity score analysis from a French multicentric cohort. Langenbeck's Archives of Surgery, Springer Verlag, 2018, 403 (6), pp.701-709. ⟨10.1007/s00423-018-1702-1⟩. ⟨hal-01862576⟩

Share

Metrics

Record views

113